FDA MedWatch - Green Valley Drugs: Recall of All Lots of All Sterile Products - Quality Control Concerns

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - Green Valley Drugs: Recall of All Lots of All Sterile Products - Quality Control Concerns
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

Green Valley Drugs: Recall of All Lots of All Sterile Products - Quality Control Concerns

AUDIENCE: Healthcare Professional, Consumer

ISSUE: Green Valley Drugs notified healthcare professionals and their organizations about the recall of all lots of all sterile products compounded, repackaged, and distributed by the pharmacy due to lack of sterility assurance and concerns associated with the quality control processes. A full list of the recalled products (name, lot # and Beyond Use date) is linked from the press release or can be accessed at greenvalleymed.com. Green Valley Drugs sterile products covered under this recall were distributed nationwide.

BACKGROUND: The recall of sterile products is conducted based on observations of clean room personnel and certain aseptic techniques. Green Valley has received no reports of injury or illness associated with the use of the products.

RECOMMENDATIONS: Until further notice, healthcare providers should stop using all lots of sterile products and return them to the company. Consumers or healthcare providers with questions regarding this recall may contact Green Valley Drugs by phone at 702-564-2079 Monday through Friday between the hours of 9 am to 5 pm PST, or by e-mail at pharmacy@xxxxxxxxxxxxxxxxxx. Patients who have received any product distributed by Green Valley Drugs and have concerns should contact their healthcare provider.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch safety alert, including a link to the Press Release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm347755.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux